Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial

Author:

Vardeny Orly12,Claggett Brian3,Kachadourian Jessica4,Desai Akshay S.3,Packer Milton5,Rouleau Jean6,Zile Michael R.7,Swedberg Karl8,Lefkowitz Martin4,Shi Victor4,McMurray John J.V.9,Solomon Scott D.3

Affiliation:

1. Center for Care Delivery and Outcomes ResearchVA Health Care System Minneapolis MN USA

2. Department of MedicineUniversity of Minnesota Minneapolis MN USA

3. Division of Cardiovascular Medicine, Brigham and Women's HospitalHarvard University Boston MA USA

4. Novartis Pharmaceuticals Corporation East Hanover NJ USA

5. Baylor Heart and Vascular Institute, Baylor University Medical Center Dallas TX USA

6. Montreal Heart Institute and University of Montreal Montreal, Québec Canada

7. Department of MedicineMedical University of South Carolina, and the RHJ Department of Veterans Affairs Medical Center Charleston SC USA

8. Department of Molecular and Clinical MedicineUniversity of Gothenburg Gothenburg Sweden

9. British Heart Foundation and Institute of Cardiovascular and Medical SciencesUniversity of Glasgow Glasgow UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Cited by 127 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3